Business
-
Teva Pharmaceuticals said that it has launched a generic version of Perforomist formoterol fumarate inhalation solution for the treatment of COPD in the US. Perforomist was approved by the FDA in 2007; Teva first submitted… Read more . . .
-
Valeo Pharma has announced the launch of the Enerzair Breezhaler indacaterol / glycopyrronium / mometasone furoate and Atectura Breezhaler indacaterol / mometasone furoate DPIs in Canada. The company acquired Canadian rights to the two Novartis dry powder inhalers… Read more . . .
-
Inhalation CDMO Vectura has announced an agreement to provide preclinical development services for Incannex Healthcare’s IHL-216A CBD/isoflurane, which Incannex is developing for the treatment of traumatic brain injury. In addition to performing screening, stability, and optimization… Read more . . .
-
ENA Respiratory said that it has raised up to AU$32 million for development of its INNA-051 pegylated TLR2/6 agonist nasal spray for the prevention of respiratory viruses, including COVID-19, and plans to initiate a Phase… Read more . . .
-
Glenmark Pharmaceuticals has announced the launch of its Tiogiva tiotropium bromide DPI in the UK for the treatment of COPD. The company announced in August 2018 that it had acquired the rights to market the… Read more . . .
-
Taiba Middle East announced that it has acquired exclusive distribution and marketing rights to Insmed’s Arikayce amikacin liposome inhalation suspension in Saudi Arabia, UAE, Kuwait, Oman, Qatar, and Bahrain, the six countries that make up… Read more . . .
-
MannKind Corporation will develop a dry powder formulation of Thirona Bio’s FBM5712 ALK-5 kinase inhibitor, the companies have announced. The deal gives MannKind the option to license the compound for the treatment of fibrotic diseases in the lung and… Read more . . .
-
Nuance Pharma will pay $25 million in cash, plus equity in its parent company Nuance Biotech valued at $15 million, as well as potential milestone payments worth up to $179 million to Verona Pharma for… Read more . . .
-
Nuformix said that it has received a Notice of Allowance for US Patent Application No. 17/051,592 titled, “Crystalline Tranilast Salts and Their Pharmaceutical Use.” The company has already been granted one patent covering crystalline forms… Read more . . .
-
Lupin has announced the US launch of an authorized generic version of Sunovion’s Brovana arformoterol tartrate inhalation solution for the treatment of COPD. The FDA tentatively approved the company’s ANDA for the inhalation solution in… Read more . . .

Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
May 30-June 2: ISAM Congress 2027, Dublin, Ireland
June 23: SMI London, London, UK

